PRNP and prion disease: To test functional relevance of the structural observation, we created mutations and tested their apparent activity using the aforementioned FACS assay with two endogenous GPI-AP markers: CD59, a membrane complement regulator that inhibits the formation of the membrane attack complex, and prion protein (PrP), a glycoprotein that causes prion diseases when misfolded.